SKI Market

Indian Indices

Nifty

24,579.60 -45.45
(-0.18%)

Sensex

80,157.88 -206.61
( -0.26%)

Bank Nifty

53,661.00 -341.45
( -0.63%)

Nifty IT

35,737.90 -2.75
( -0.01%)

Global Indices

Nasdaq

45,565.88 -92.03
(-0.20%)

Dow Jones

6,481.26 -41.60
(-0.64%)

Hang Seng

42,288.11 99.32
(0.24%)

Nikkei 225

9,116.69 -79.65
(-0.87%)

Forex

USD-INR

88.15 0.55
(0.63%)

EUR-INR

103.00 0.84
(0.82%)

GBP-INR

118.99 0.66
(0.55%)

JPY-INR

0.60 0.00
(0.61%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aatmaj Healthcare Ltd

Industry : Healthcare

BSE Code

ISIN Demat

Book Value()

78782

INE0OB201016

22.1776549

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AATMAJ

68.21

43.17

EPS(TTM)

Face Value()

Div & Yield %

0.28

Back

adani ports & special economic zone ltd

Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Press Release

Aug 19,2025

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 19, 2025, titled 'Glenmark Pharmaceuticals Inc., USA to launch Micafungin for Injection USP, 50 mg/vial and 100 mg/vial (Single-Dose Vial)'.

24,579.60 -45.45 (-0.18%)

80,157.88 -206.61 ( -0.26%)

53,661.00 -341.45 ( -0.63%)

35,737.90 -2.75 ( -0.01%)

45,565.88 -92.03 (-0.20%)

6,481.26 -41.60 (-0.64%)

42,288.11 99.32 (0.24%)

9,116.69 -79.65 (-0.87%)

88.15 0.55 (0.63%)

103.00 0.84 (0.82%)

118.99 0.66 (0.55%)

0.60 0.00 (0.61%)